APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lipid Nanoparticle Solutions Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchLipid Nanoparticle Solutions Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle Solutions Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle Solutions Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global Lipid Nanoparticle Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Nanoparticle Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lipid Nanoparticle Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lipid Nanoparticle Solutions market include Merck, Cytiva, GenScript, Creative Biolabs, WuXi STA, Carcell, Croda International, Detai Biotechnology and Waters, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Lipid Nanoparticle Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lipid Nanoparticle Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lipid Nanoparticle Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lipid Nanoparticle Solutions market.

Lipid Nanoparticle Solutions Segment by Company

Merck

Cytiva

GenScript

Creative Biolabs

WuXi STA

Carcell

Croda International

Detai Biotechnology

Waters

MicroNano Biologics

Precigenome

Evonik

Avanti Polar Lipids

Genevant Sciences

Exelead

Nippon Fine Chemical

Lipoid

Lipid Nanoparticle Solutions Segment by Type

Solid Lipid Nanoparticles

Nanostructured Lipid Carriers

Cationic Lipid-Nucleic Acid Complexes

Lipid Nanoparticle Solutions Segment by Application

Gene Therapy

Vaccine Development

Cancer Treatment

Lipid Nanoparticle Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lipid Nanoparticle Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lipid Nanoparticle Solutions key companies, revenue, market share, and recent developments.

3. To split the Lipid Nanoparticle Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lipid Nanoparticle Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lipid Nanoparticle Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Lipid Nanoparticle Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lipid Nanoparticle Solutions industry.

Chapter 3: Detailed analysis of Lipid Nanoparticle Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lipid Nanoparticle Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lipid Nanoparticle Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lipid Nanoparticle Solutions Industry Trends Table 2. Lipid Nanoparticle Solutions Industry Drivers Table 3. Lipid Nanoparticle Solutions Industry Opportunities and Challenges Table 4. Lipid Nanoparticle Solutions Industry Restraints Table 5. Global Lipid Nanoparticle Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lipid Nanoparticle Solutions Revenue Share by Company (2021-2026) Table 7. Global Lipid Nanoparticle Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lipid Nanoparticle Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Lipid Nanoparticle Solutions Company, Product Type & Application Table 10. Global Lipid Nanoparticle Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lipid Nanoparticle Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Solid Lipid Nanoparticles Table 15. Significant Companies of Nanostructured Lipid Carriers Table 16. Significant Companies of Cationic Lipid-Nucleic Acid Complexes Table 17. Global Lipid Nanoparticle Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Lipid Nanoparticle Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Lipid Nanoparticle Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Lipid Nanoparticle Solutions Sales Value Share by Type (2021-2026) Table 21. Global Lipid Nanoparticle Solutions Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Gene Therapy Table 23. Significant Companies of Vaccine Development Table 24. Significant Companies of Cancer Treatment Table 25. Global Lipid Nanoparticle Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Lipid Nanoparticle Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Lipid Nanoparticle Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Lipid Nanoparticle Solutions Sales Value Share by Application (2021-2026) Table 29. Global Lipid Nanoparticle Solutions Sales Value Share by Application (2027-2032) Table 30. Global Lipid Nanoparticle Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Lipid Nanoparticle Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Lipid Nanoparticle Solutions Sales Value Share by Region (2021-2026) Table 33. Global Lipid Nanoparticle Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Lipid Nanoparticle Solutions Sales Value Share by Region (2027-2032) Table 35. Global Lipid Nanoparticle Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Lipid Nanoparticle Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Lipid Nanoparticle Solutions Sales Value Market Share by Country (2021-2026) Table 38. Global Lipid Nanoparticle Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Lipid Nanoparticle Solutions Sales Value Market Share by Country (2027-2032) Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Merck Lipid Nanoparticle Solutions Product Portfolio Table 44. Merck Recent Development Table 45. Cytiva Company Information Table 46. Cytiva Business Overview Table 47. Cytiva Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Cytiva Lipid Nanoparticle Solutions Product Portfolio Table 49. Cytiva Recent Development Table 50. GenScript Company Information Table 51. GenScript Business Overview Table 52. GenScript Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. GenScript Lipid Nanoparticle Solutions Product Portfolio Table 54. GenScript Recent Development Table 55. Creative Biolabs Company Information Table 56. Creative Biolabs Business Overview Table 57. Creative Biolabs Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio Table 59. Creative Biolabs Recent Development Table 60. WuXi STA Company Information Table 61. WuXi STA Business Overview Table 62. WuXi STA Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. WuXi STA Lipid Nanoparticle Solutions Product Portfolio Table 64. WuXi STA Recent Development Table 65. Carcell Company Information Table 66. Carcell Business Overview Table 67. Carcell Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Carcell Lipid Nanoparticle Solutions Product Portfolio Table 69. Carcell Recent Development Table 70. Croda International Company Information Table 71. Croda International Business Overview Table 72. Croda International Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Croda International Lipid Nanoparticle Solutions Product Portfolio Table 74. Croda International Recent Development Table 75. Detai Biotechnology Company Information Table 76. Detai Biotechnology Business Overview Table 77. Detai Biotechnology Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio Table 79. Detai Biotechnology Recent Development Table 80. Waters Company Information Table 81. Waters Business Overview Table 82. Waters Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Waters Lipid Nanoparticle Solutions Product Portfolio Table 84. Waters Recent Development Table 85. MicroNano Biologics Company Information Table 86. MicroNano Biologics Business Overview Table 87. MicroNano Biologics Lipid Nanoparticle Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio Table 89. MicroNano Biologics Recent Development Table 90. Precigenome Company Information Table 91. Precigenome Business Overview Table 92. Precigenome Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Precigenome Lipid Nanoparticle Solutions Product Portfolio Table 94. Precigenome Recent Development Table 95. Evonik Company Information Table 96. Evonik Business Overview Table 97. Evonik Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Evonik Lipid Nanoparticle Solutions Product Portfolio Table 99. Evonik Recent Development Table 100. Avanti Polar Lipids Company Information Table 101. Avanti Polar Lipids Business Overview Table 102. Avanti Polar Lipids Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio Table 104. Avanti Polar Lipids Recent Development Table 105. Genevant Sciences Company Information Table 106. Genevant Sciences Business Overview Table 107. Genevant Sciences Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio Table 109. Genevant Sciences Recent Development Table 110. Exelead Company Information Table 111. Exelead Business Overview Table 112. Exelead Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Exelead Lipid Nanoparticle Solutions Product Portfolio Table 114. Exelead Recent Development Table 115. Nippon Fine Chemical Company Information Table 116. Nippon Fine Chemical Business Overview Table 117. Nippon Fine Chemical Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio Table 119. Nippon Fine Chemical Recent Development Table 120. Lipoid Company Information Table 121. Lipoid Business Overview Table 122. Lipoid Lipid Nanoparticle Solutions Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Lipoid Lipid Nanoparticle Solutions Product Portfolio Table 124. Lipoid Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Lipid Nanoparticle Solutions Product Image Figure 2. Global Lipid Nanoparticle Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid Nanoparticle Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Lipid Nanoparticle Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Solid Lipid Nanoparticles Image Figure 8. Nanostructured Lipid Carriers Image Figure 9. Cationic Lipid-Nucleic Acid Complexes Image Figure 10. Global Lipid Nanoparticle Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Lipid Nanoparticle Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Lipid Nanoparticle Solutions Sales Value Share by Type (2021-2032) Figure 13. Gene Therapy Image Figure 14. Vaccine Development Image Figure 15. Cancer Treatment Image Figure 16. Global Lipid Nanoparticle Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Lipid Nanoparticle Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Lipid Nanoparticle Solutions Sales Value Share by Application (2021-2032) Figure 19. Global Lipid Nanoparticle Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Lipid Nanoparticle Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Lipid Nanoparticle Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. North America Lipid Nanoparticle Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Lipid Nanoparticle Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Lipid Nanoparticle Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Lipid Nanoparticle Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Lipid Nanoparticle Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Lipid Nanoparticle Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. South America Lipid Nanoparticle Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Lipid Nanoparticle Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Lipid Nanoparticle Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
  • Cationic Lipid-Nucleic Acid Complexes
Applications
  • Gene Therapy
  • Vaccine Development
  • Cancer Treatment
Companies covered
  • Merck
  • Cytiva
  • GenScript
  • Creative Biolabs
  • WuXi STA
  • Carcell
  • Croda International
  • Detai Biotechnology
  • Waters
  • MicroNano Biologics
  • Precigenome
  • Evonik
  • Avanti Polar Lipids
  • Genevant Sciences
  • Exelead
  • Nippon Fine Chemical
  • Lipoid

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lipid Nanoparticle Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lipid Nanoparticle Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lipid Nanoparticle Solutions Market Dynamics
  1. 2.1 Lipid Nanoparticle Solutions Industry Trends
  2. 2.2 Lipid Nanoparticle Solutions Industry Drivers
  3. 2.3 Lipid Nanoparticle Solutions Industry Opportunities and Challenges
  4. 2.4 Lipid Nanoparticle Solutions Industry Restraints
3 Lipid Nanoparticle Solutions Market by Company
  1. 3.1 Global Lipid Nanoparticle Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Lipid Nanoparticle Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Lipid Nanoparticle Solutions Company Ranking (2024-2026)
  4. 3.4 Global Lipid Nanoparticle Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Lipid Nanoparticle Solutions Company Product Type and Application
  6. 3.6 Global Lipid Nanoparticle Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lipid Nanoparticle Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lipid Nanoparticle Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lipid Nanoparticle Solutions Market by Type
  1. 4.1 Lipid Nanoparticle Solutions Type Introduction
  2. 4.1.1 Solid Lipid Nanoparticles
  3. 4.1.2 Nanostructured Lipid Carriers
  4. 4.1.3 Cationic Lipid-Nucleic Acid Complexes
  5. 4.2 Global Lipid Nanoparticle Solutions Sales Value by Type
  6. 4.2.1 Global Lipid Nanoparticle Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lipid Nanoparticle Solutions Sales Value by Type (2021-2032)
  8. 4.2.3 Global Lipid Nanoparticle Solutions Sales Value Share by Type (2021-2032)
5 Lipid Nanoparticle Solutions Market by Application
  1. 5.1 Lipid Nanoparticle Solutions Application Introduction
  2. 5.1.1 Gene Therapy
  3. 5.1.2 Vaccine Development
  4. 5.1.3 Cancer Treatment
  5. 5.2 Global Lipid Nanoparticle Solutions Sales Value by Application
  6. 5.2.1 Global Lipid Nanoparticle Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lipid Nanoparticle Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Lipid Nanoparticle Solutions Sales Value Share by Application (2021-2032)
6 Lipid Nanoparticle Solutions Regional Value Analysis
  1. 6.1 Global Lipid Nanoparticle Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lipid Nanoparticle Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lipid Nanoparticle Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lipid Nanoparticle Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lipid Nanoparticle Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Lipid Nanoparticle Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lipid Nanoparticle Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Lipid Nanoparticle Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lipid Nanoparticle Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lipid Nanoparticle Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lipid Nanoparticle Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Lipid Nanoparticle Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lipid Nanoparticle Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lipid Nanoparticle Solutions Sales Value Share by Country, 2025 VS 2032
7 Lipid Nanoparticle Solutions Country-level Value Analysis
  1. 7.1 Global Lipid Nanoparticle Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lipid Nanoparticle Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lipid Nanoparticle Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lipid Nanoparticle Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lipid Nanoparticle Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lipid Nanoparticle Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lipid Nanoparticle Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Lipid Nanoparticle Solutions Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Cytiva
  8. 8.2.1 Cytiva Company Information
  9. 8.2.2 Cytiva Business Overview
  10. 8.2.3 Cytiva Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cytiva Lipid Nanoparticle Solutions Product Portfolio
  12. 8.2.5 Cytiva Recent Developments
  13. 8.3 GenScript
  14. 8.3.1 GenScript Company Information
  15. 8.3.2 GenScript Business Overview
  16. 8.3.3 GenScript Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GenScript Lipid Nanoparticle Solutions Product Portfolio
  18. 8.3.5 GenScript Recent Developments
  19. 8.4 Creative Biolabs
  20. 8.4.1 Creative Biolabs Company Information
  21. 8.4.2 Creative Biolabs Business Overview
  22. 8.4.3 Creative Biolabs Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biolabs Lipid Nanoparticle Solutions Product Portfolio
  24. 8.4.5 Creative Biolabs Recent Developments
  25. 8.5 WuXi STA
  26. 8.5.1 WuXi STA Company Information
  27. 8.5.2 WuXi STA Business Overview
  28. 8.5.3 WuXi STA Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 WuXi STA Lipid Nanoparticle Solutions Product Portfolio
  30. 8.5.5 WuXi STA Recent Developments
  31. 8.6 Carcell
  32. 8.6.1 Carcell Company Information
  33. 8.6.2 Carcell Business Overview
  34. 8.6.3 Carcell Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Carcell Lipid Nanoparticle Solutions Product Portfolio
  36. 8.6.5 Carcell Recent Developments
  37. 8.7 Croda International
  38. 8.7.1 Croda International Company Information
  39. 8.7.2 Croda International Business Overview
  40. 8.7.3 Croda International Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Croda International Lipid Nanoparticle Solutions Product Portfolio
  42. 8.7.5 Croda International Recent Developments
  43. 8.8 Detai Biotechnology
  44. 8.8.1 Detai Biotechnology Company Information
  45. 8.8.2 Detai Biotechnology Business Overview
  46. 8.8.3 Detai Biotechnology Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Detai Biotechnology Lipid Nanoparticle Solutions Product Portfolio
  48. 8.8.5 Detai Biotechnology Recent Developments
  49. 8.9 Waters
  50. 8.9.1 Waters Company Information
  51. 8.9.2 Waters Business Overview
  52. 8.9.3 Waters Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Waters Lipid Nanoparticle Solutions Product Portfolio
  54. 8.9.5 Waters Recent Developments
  55. 8.10 MicroNano Biologics
  56. 8.10.1 MicroNano Biologics Company Information
  57. 8.10.2 MicroNano Biologics Business Overview
  58. 8.10.3 MicroNano Biologics Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MicroNano Biologics Lipid Nanoparticle Solutions Product Portfolio
  60. 8.10.5 MicroNano Biologics Recent Developments
  61. 8.11 Precigenome
  62. 8.11.1 Precigenome Company Information
  63. 8.11.2 Precigenome Business Overview
  64. 8.11.3 Precigenome Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Precigenome Lipid Nanoparticle Solutions Product Portfolio
  66. 8.11.5 Precigenome Recent Developments
  67. 8.12 Evonik
  68. 8.12.1 Evonik Company Information
  69. 8.12.2 Evonik Business Overview
  70. 8.12.3 Evonik Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Evonik Lipid Nanoparticle Solutions Product Portfolio
  72. 8.12.5 Evonik Recent Developments
  73. 8.13 Avanti Polar Lipids
  74. 8.13.1 Avanti Polar Lipids Company Information
  75. 8.13.2 Avanti Polar Lipids Business Overview
  76. 8.13.3 Avanti Polar Lipids Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Avanti Polar Lipids Lipid Nanoparticle Solutions Product Portfolio
  78. 8.13.5 Avanti Polar Lipids Recent Developments
  79. 8.14 Genevant Sciences
  80. 8.14.1 Genevant Sciences Company Information
  81. 8.14.2 Genevant Sciences Business Overview
  82. 8.14.3 Genevant Sciences Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Genevant Sciences Lipid Nanoparticle Solutions Product Portfolio
  84. 8.14.5 Genevant Sciences Recent Developments
  85. 8.15 Exelead
  86. 8.15.1 Exelead Company Information
  87. 8.15.2 Exelead Business Overview
  88. 8.15.3 Exelead Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Exelead Lipid Nanoparticle Solutions Product Portfolio
  90. 8.15.5 Exelead Recent Developments
  91. 8.16 Nippon Fine Chemical
  92. 8.16.1 Nippon Fine Chemical Company Information
  93. 8.16.2 Nippon Fine Chemical Business Overview
  94. 8.16.3 Nippon Fine Chemical Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Nippon Fine Chemical Lipid Nanoparticle Solutions Product Portfolio
  96. 8.16.5 Nippon Fine Chemical Recent Developments
  97. 8.17 Lipoid
  98. 8.17.1 Lipoid Company Information
  99. 8.17.2 Lipoid Business Overview
  100. 8.17.3 Lipoid Lipid Nanoparticle Solutions Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lipoid Lipid Nanoparticle Solutions Product Portfolio
  102. 8.17.5 Lipoid Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst